786 o cas9 cells (Genecopoeia)
Structured Review

786 O Cas9 Cells, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/single+cell+expression+data/Human+cell+line+786-O+stably+expressing+Cas9%2C+randomly+inserted%2C+single+clone/pmc11178540-202-0-6
Average 94 stars, based on 7 article reviews
Images
1) Product Images from "HIF-2 α expression and metabolic signaling require ACSS2 in clear cell renal cell carcinoma"
Article Title: HIF-2 α expression and metabolic signaling require ACSS2 in clear cell renal cell carcinoma
Journal: The Journal of Clinical Investigation
doi: 10.1172/JCI164249
Figure Legend Snippet: ( A ) Left: Representative images of crystal violet staining of HEK293FT cells 72 hours after transfection with an empty vector control (EV), WT-ACSS2, or ΔT376K catalytically inactive mutant. Right: Bar graph showing quantification of 3 independent experiments in HEK293FT cells. Statistical significance was determined using a 1-way ANOVA and Tukey’s multiple-comparison test (* P < 0.05; ** P < 0.01). Data are represented as mean ± SD. ( B ) Western blot images showing expression of HIF-2α ( n = 3), ACSS2 ( n = 3), and actin ( n = 3) in 786-O Cas9 sgControl and sgACSS2 cells transfected with EV, WT-ACSS2, or ΔT376K. ( C ) Left: Representative images of crystal violet staining of 786-O Cas9 cells stably transduced to express sgControl or sgACSS2 72 hours after transfection with an empty vector control (EV), WT-ACSS2, or ΔT376K catalytically inactive mutant. Right: Bar graph showing quantification of 3 independent experiments in 786-O Cas9 cells. Statistical significance was determined using a 2-way ANOVA and Tukey’s multiple-comparison test (* P < 0.05; ** P < 0.01). Data are represented as mean ± SD. ( D ) Representative images from day 4 of a tumor sphere formation assay where 786-O Cas9 sgControl and sgACSS2 cells were transfected with EV, WT-ACSS2, or ΔT376K.
Techniques Used: Staining, Transfection, Plasmid Preparation, Control, Mutagenesis, Comparison, Western Blot, Expressing, Stable Transfection, Tube Formation Assay
Related Articles
Plasmid Preparation:Article Title: circRNA DENND1B inhibits tumorigenicity of clear cell renal cell carcinoma via miR-122-5p/TIMP2 axis Article Snippet: .. The reporter plasmid and Luciferase:Article Title: circRNA DENND1B inhibits tumorigenicity of clear cell renal cell carcinoma via miR-122-5p/TIMP2 axis Article Snippet: .. The reporter plasmid and Activity Assay:Article Title: circRNA DENND1B inhibits tumorigenicity of clear cell renal cell carcinoma via miR-122-5p/TIMP2 axis Article Snippet: .. The reporter plasmid and Reporter Assay:Article Title: circRNA DENND1B inhibits tumorigenicity of clear cell renal cell carcinoma via miR-122-5p/TIMP2 axis Article Snippet: .. The reporter plasmid and Transfection:Article Title: miR-502-mediated histone methyltransferase SET8 expression is associated with clear cell renal cell carcinoma risk Article Snippet: The renal carcinoma 786-O cell line was purchased from the Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (Shanghai, China) and cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS), 50 IU/ml penicillin and 50 mg/ml streptomycin (all Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) at 37°C in a standard humidified incubator containing 5% CO 2 . .. The renal Article Title: Enhancement of Proliferation and Invasion by MicroRNA-590-5p via Targeting PBRM1 in Clear Cell Renal Carcinoma Cells Article Snippet: Address correspondence to Pingping Yu, Xiangya Hospital, Central-South University, Changsha 410008, China.. Tel/Fax: +86-731-13574164457; E-mail: pingpingyu2004@163.com Oncology Research, Vol.. 20, pp. Cell Counting:Article Title: Upregulation of microRNA-492 induced by epigenetic drug treatment inhibits the malignant phenotype of clear cell renal cell carcinoma in vitro. Article Snippet: .. The human ccRCC cell lines, Proliferation Assay:Article Title: Upregulation of microRNA-492 induced by epigenetic drug treatment inhibits the malignant phenotype of clear cell renal cell carcinoma in vitro. Article Snippet: .. The human ccRCC cell lines, Transduction:Article Title: Nanotechnology combined therapy: tyrosine kinase-bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model. Article Snippet: Objective: To investigate tyrosine kinase inhibitors (TKI) and gold nanorod (AuNR) paired with photothermal ablation in a human metastatic clear cell renal cell carcinoma mouse model. Nanoparticles have been successful as platform for targeted drug delivery in the treatment of urologic cancers.. Likewise, the use of nanoparticles in photothermal tumor ablation, though early in its development, has provided promising results.. Our previous in vitro studies of nanoparticles loaded with both TKI and gold nanorods and activated with photothermal ablation have demonstrated significant synergistic cell kill greater than each individual arm alone. Construct:Article Title: Nanotechnology combined therapy: tyrosine kinase-bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model. Article Snippet: Objective: To investigate tyrosine kinase inhibitors (TKI) and gold nanorod (AuNR) paired with photothermal ablation in a human metastatic clear cell renal cell carcinoma mouse model. Nanoparticles have been successful as platform for targeted drug delivery in the treatment of urologic cancers.. Likewise, the use of nanoparticles in photothermal tumor ablation, though early in its development, has provided promising results.. Our previous in vitro studies of nanoparticles loaded with both TKI and gold nanorods and activated with photothermal ablation have demonstrated significant synergistic cell kill greater than each individual arm alone. |

